Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 14, 2022
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
[ Wed, Sep 14th 2022
] - WOPRAI
Tue, September 13, 2022
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
[ Tue, Sep 13th 2022
] - WOPRAI
John Lee Downgraded (ANAB) to Hold and Decreased Target to $28 on, Sep 13th, 2022
John Lee of Truist Securities, Downgraded "AnaptysBio, Inc." (ANAB) to Hold and Decreased Target from $50 to $28 on, Sep 13th, 2022.
John has made no other calls on ANAB in the last 4 months.
There is 1 other peer that has a rating on ANAB. Out of the 1 peers that are also analyzing ANAB, 0 agree with John's Rating of Hold.
This is the rating of the analyst that currently disagrees with John
- Steven Seedhouse of "Raymond James" Initiated at Buy and Held Target at $35 on, Thursday, September 1st, 2022
